Skip to main content Accessibility help
×
Home

Platelet Monoamine Oxidase Activity in Schizophrenia: Relationship to Disease, Treatment, Institutionalization and Outcome

  • John Mann (a1) and K. M. Thomas (a2)

Summary

A study was made of platelet monoamine oxidase (MAO) activity in non-medicated, newly-admitted schizophrenics and institutionalized chronic schizophrenics both on and off medication. These patients were compared to two control groups: normal subjects and brain-damaged institutionalized patients. No relationship was found between platelet MAO activity and the severity or duration of illness, duration of psychotropic medication, presence of auditory hallucinations or institutionalization. Mean platelet MAO activity did not differ significantly between the schizophrenic subgroups and control groups. Thirty-one patients studied before and after treatment with phenothiazines showed no significant change in platelet MAO activity. The findings did not indicate a relationship between schizophrenia, its treatment or outcome and platelet MAO activity.

Copyright

References

Hide All
Becker, R. E. & Shaskan, E. G. (1977) Platelet monoamine oxidase activity in schizophrenic patients. American Journal of Psychiatry, 134, 512–7.
Berrettini, W. H., Vogel, W. H. & Clouse, R. (1977) Platelet monoamine oxidase in chronic schizophrenia. American Journal of Psychiatry, 134, 805–6.
Breese, G. R. & Taylor, T. D. (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective destruction of catecholamine neurons. Journal of Pharmacology and Experimental Therapeutics, 174, 412–20.
Brockington, I., Crow, T. J., Johnstone, E. C. & Owen, F. (1976) An investigation of platelet monoamine oxidase activity in schizophrenia and schizoaffective psychosis. In Monoamine Oxidase and its Inhibition. Ciba Foundation Symposium 39 (new series), pp 353–62. Amsterdam: Associated Scientific Publishers.
Carpenter, W. T., Murphy, D. L. & Wyatt, R. J. (1975) Platelet monoamine oxidase activity in acute schizophrenia. American Journal of Psychiatry, 132, 438–41.
Domino, E. F. & Khanna, S. S. (1976) Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients. American Journal of Psychiatry, 133, 323–6.
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 5763.
Friedman, E., Shopsin, B., Sathananthan, G. & Gershon, S. (1974) Blood platelet monoamine oxidase in psychiatric patients. American Journal of Psychiatry, 131, 1392–4.
Jarrott, B. (1974) Methods for analysing monoamine oxidase and catechol-O-methyltransferase in nervous tissue. In Research Methods in Neurochemistry, vol. 2, pp 377–88 (eds. N. Marks and R. Rodnight). New York: Plenum Press.
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–75.
Mandell, A. J. & Segal, D. S. (1973) The psychobiology of dopamine and the methylated indoleamines with particular reference to psychiatry. In Biological Psychiatry (ed. J. Mendels), pp 89112. New York: John Wiley & Sons.
Mann, J. J. & Chui, E. (1978) Platelet monoamine oxidase in Huntington's chorea. Journal of Neurology, Neurosurgery and Psychiatry, in press.
Meltzer, H. Y. & Stahl, S. M. (1974) Platelet monoamine oxidase and substrate preferences in schizophrenic patients. Research Communications in Chemical Pathology and Pharmacology, 7, 419–31.
Murphy, D. L. & Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. American Journal of Psychiatry, 128, 3541.
Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L. & Wyatt, R. J. (1976) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biological Medicine, 16, 254–65.
Murphy, D. L. & Wyatt, R. J. (1972) Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature, 238, 225–6.
Nies, A., Robinson, D. S., Harris, L. S. & Lamborn, K. R. (1974) Comparison of monoamine oxidase substrate activity in twins, schizophrenics, depressives and controls. Advances in Biochemical Psychopharmacology, 12, 5970.
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799812.
Owen, F., Bourne, R., Crow, T. J., Johnstone, E. C., Bailey, A. R. & Hershon, H. I. (1976) Platelet monoamine oxidase in schizophrenia: an investigation in drug-free chronic hospitalized patients. Archives of General Psychiatry, 33, 1370–3.
Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L. & Sylwester, D. (1971) Relation of sex and ageing to monoamine oxidase activity of human brain, plasma and platelets. Archives of General Psychiatry, 24, 536–9.
Sandler, M. & Reynolds, G. P. (1976) Does phenylethylamine cause schizophrenia ? Lancet, i, 70–1.
Schildkraut, J. J., Herzog, J. M., Orsulak, P. J., Edelman, S. E., Shein, H. M. & Frazier, S. H. (1976) Reduced platelet monoamine oxidase activity in a sub-group of schizophrenic patients. American Journal of Psychiatry, 133, 438–40.
Schneider, K. (1959) Clinical Psychopathology. Translated by Hamilton, M. New York: Grune and Stratton.
Smythies, J. R. (1976) Recent progress in schizophrenia research. Lancet, ii, 136–9.
Snyder, S. H., Banerjee, S. P., Yamamura, H. I. & Greenberg, D. (1974) Drugs, neurotransmitters and schizophrenia. Phenothiazines, amphetamines, and enzymes synthesizing psychotomimetic drugs aid schizophrenia research. Science, 184, 1243–53.
Suluvan, J., Stanfield, C. N. & Dackis, C. (1977) Platelet MAO activity in schizophrenia and other psychiatric illnesses. American Journal of Psychiatry, 134, 10981103.
Takahashi, S., Yamane, H. & Tani, N. (1975) Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines. Folia Psychiatrica et Neurologica Japonica, 29, 207–14.
Wing, J. K. & Brown, G. W. (1970) Institutionalism and Schizophrenia. London: Cambridge University Press.
Wyatt, R. J. & Murphy, D. L. (1976) Low platelet monoamine oxidase activity and schizophrenia. Schizophrenia Bulletin, 2, 7789.
Zeller, E. A., Boshes, B., Arbit, J., Bieber, M., Blonsky, E. R., Dolkart, M. & Huprikar, S. V. (1976) Molecular biology of neurological and psychiatric disorders. 1. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase. Journal of Neurotransmission, 39, 63–7.
Zeller, E. A., Boshes, B., Davis, J. M. & Thorner, M. (1975) Letter: molecular aberration in platelet monoamine oxidase in schizophrenia. Lancet, i, 1385.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Platelet Monoamine Oxidase Activity in Schizophrenia: Relationship to Disease, Treatment, Institutionalization and Outcome

  • John Mann (a1) and K. M. Thomas (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *